{
  "abstract": "Headache is a common presenting complaint, with secondary causes being rare. SNOOP 10 criteria can be used to identify sinister headaches. This criteria includes systematic symptoms, history of neoplasm, and neurologic deficit, among others.This audit looked at 630 patients referred on the 2 week-wait pathway for brain tumour, assessed using MRI head. Data reviewed included the indication for scan (e.g. headache or focal neurology), if they were SNOOP 10 positive (if they had a headache), and the findings of the MRI.614 patients were scanned. 9 tumours were found (1.5% of those scanned), with one being previously diagnosed. Of the patients with a tumour, 55% had a headache and SNOOP10 was positive in all. Of the patients referred, 510 had a headache, and 14% did not meet SNOOP10 criteria. None of the SNOOP10 negative patients had a tumour. There were other incidental findings, including 17 meningiomas, and 30% with vascular changes.These findings suggests that the SNOOP10 criteria could be used to screen all potential brain tumour referrals that present with a headache. We propose that NICE guidance may need further adaption, with stricter guidance to reduce unnecessary scans, which could cut costs and reduce waiting times.s.mcgough1@nhs.net",
  "authors": [
    {
      "affiliations": [
        "Leeds Teaching Hospitals NHS Trust"
      ],
      "name": "McGough Sophie"
    },
    {
      "affiliations": [
        "University of Leeds"
      ],
      "name": "Bock Iulia"
    },
    {
      "affiliations": [
        "Leeds Teaching Hospitals NHS Trust"
      ],
      "name": "Randall Marc"
    }
  ],
  "title": "61 2 week wait brain tumour referrals: should the guidelines be reviewed?",
  "uid": "0c2e8351-e0b0-5140-b744-d0822a61c887"
}